Comparing CT-guided Lung Biopsy vs Shape-Sensing Robotic Bronchoscopy for Small Nodules
Official title: A Randomized Controlled Trial Evaluating Lung Nodules - COMparing Percutaneous CT-Guided Biopsy And Shape-Sensing Robotic-Assisted Bronchoscopy (ENCOMPASS)
Run by Intuitive Surgical · NCT07761351 · Data updated 2026-11-12
This trial tests whether shape-sensing robotic-assisted bronchoscopy with cone-beam CT can diagnose small lung nodules as well as the standard CT-guided lung biopsy, with a focus on safety.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 550 (estimated) |
| Sponsor | Intuitive Surgical Industry-sponsored |
| Locations | 3 sites (Heidelberg and 2 other locations) |
| Status | Recruiting |
| Started | August 28, 2026 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2029 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT07761351 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a target pulmonary nodule ≤2 cm requiring diagnostic biopsy and who can provide informed consent.
✕Probably not a fit
Patients for whom the assigned biopsy method is unsuitable or who do not derive diagnostic benefit from biopsy may not experience improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ENCOMPASS trial is a multicenter, randomized study of adults with diagnostic nodules 2 cm or smaller to compare two biopsy approaches. Participants are randomly assigned to shape-sensing robotic-assisted bronchoscopy with cone-beam CT or to CT-guided percutaneous biopsy. The study aims to show non-inferior diagnostic efficacy and superior safety for the robotic approach, with peri-procedural pneumothorax as a key safety endpoint. Procedures follow standard clinical practice, and patients are followed up to 12 months with health status and quality-of-life assessments. If a patient’s assigned procedure is deemed unsuitable by the clinical team, they receive the best available standard care instead.
Why it matters
Potential benefit: If successful, patients with small pulmonary nodules could benefit from a biopsy method that provides similar diagnostic results with improved safety.
How similar studies have gone: Prior research has explored both CT-guided and robotic-assisted bronchoscopy approaches, with ongoing evaluation of safety and diagnostic yield in similar settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient is aged 18 years or older at time of consent. 2. Diagnostic nodule biopsy(s) indicated per multidisciplinary team (or equivalent). 3. Target pulmonary nodule ≤2 cm in largest diameter. 4. Patient is willing and able to give written informed consent for clinical study participation. Exclusion Criteria: 1. Patient has previously undergone a biopsy procedure of the target nodule by any approach. 2. Patient was previously randomized in this study but did not undergo biopsy. 3. Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results. 4. Patient is pregnant or breastfeeding as determined by standard site practices. 5. Patient lacks the capacity to provide informed consent for themselves, or is a vulnerable patient whose ability to protect their own interests or to consent freely may be diminished, including but not limited to, patients who may be unduly influenced through dependency on the sponsor, the hospital, or the study doctor. 6. Patient is not willing to comply with study participation requirements.
Where it's running
-
Thoraxklinik Heidelberg
Heidelberg, Germany Recruiting -
Basel University Hospital
Basel, Canton of Basel-City, Switzerland Recruiting -
University College London Hospitals NHS Foundation
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Ricky Thakrar, MD — University College London Hospitals
- Study coordinator: Carine Van den Abeele
- Email: Encompass@intusurg.com
- Phone: +41 21 821 2000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting lung cancer screening for patients seen in the emergency department
This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
AI-Personalized Discharge Education After Lung Cancer Surgery
This study tests whether an AI-generated, personalized discharge guide helps patients recover better after lung cancer surgery compared with standard discharge education.
-
Next Generation Delivery System (NGDS) for SBRT in thorax and upper abdomen
A study tests a new machine to deliver SBRT more quickly and comfortably for adults with thoracic or upper abdominal cancers.
-
Low-Intensity Endurance Exercise to Help Lung Cancer-Related Fatigue
This trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer in addition to their usual care.
-
Low-Intensity Endurance Exercise for Lung Cancer-Related Fatigue
A randomized trial tests whether light, regular endurance exercise can help reduce fatigue and improve quality of life for people with lung cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.